Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory.
Strickland KC, Nesline MK, Previs RA, Ko H, Cooper M, Rushton JR, Wallen ZD, Pabla S, Conroy JM, Sausen M, Saini KS, Cantini L, Jensen TJ, Caveney BJ, Eisenberg M, Severson EA, Ramkissoon S. Strickland KC, et al. Among authors: jensen tj. Front Oncol. 2024 Oct 31;14:1445668. doi: 10.3389/fonc.2024.1445668. eCollection 2024. Front Oncol. 2024. PMID: 39544293 Free PMC article.
Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer.
Wallen ZD, Ko H, Nesline MK, Hastings SB, Strickland KC, Previs RA, Zhang S, Pabla S, Conroy J, Jackson JB, Saini KS, Jensen TJ, Eisenberg M, Caveney B, Sathyan P, Severson EA, Ramkissoon SH. Wallen ZD, et al. Among authors: jensen tj. Front Immunol. 2024 Jun 21;15:1413956. doi: 10.3389/fimmu.2024.1413956. eCollection 2024. Front Immunol. 2024. PMID: 38975340 Free PMC article.
RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
Severson E, Achyut BR, Nesline M, Pabla S, Previs RA, Kannan G, Chenn A, Zhang S, Klein R, Conroy J, Sausen M, Sathyan P, Saini KS, Ghosh A, Jensen TJ, Reddy P, Ramkissoon SH. Severson E, et al. Among authors: jensen tj. J Mol Diagn. 2023 Jul;25(7):454-466. doi: 10.1016/j.jmoldx.2023.03.011. Epub 2023 May 8. J Mol Diagn. 2023. PMID: 37164276 Free article.
Cancer testis antigen burden (CTAB): a novel biomarker of tumor-associated antigens in lung cancer.
Seager RJ, Senosain MF, Van Roey E, Gao S, DePietro P, Nesline MK, Dash DP, Zhang S, Ko H, Hastings SB, Strickland KC, Previs RA, Jensen TJ, Eisenberg M, Caveney BJ, Severson EA, Ramkissoon S, Conroy JM, Pabla S. Seager RJ, et al. Among authors: jensen tj. J Transl Med. 2024 Feb 7;22(1):141. doi: 10.1186/s12967-024-04918-0. J Transl Med. 2024. PMID: 38326843 Free PMC article.
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer.
Seager RJ, Ko H, Pabla S, Senosain MF, Kalinski P, Van Roey E, Gao S, Strickland KC, Previs RA, Nesline MK, Hastings S, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Seager RJ, et al. Among authors: jensen tj. J Pers Med. 2024 Apr 30;14(5):481. doi: 10.3390/jpm14050481. J Pers Med. 2024. PMID: 38793063 Free PMC article.
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer.
Ko HC, Seager RJ, Pabla S, Senosain MF, Van Roey E, Gao S, Strickland KC, Previs RA, Green MF, Cooper M, Nesline MK, Hastings SB, Amoah KA, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Ko HC, et al. Among authors: jensen tj. Breast Cancer (Dove Med Press). 2024 Aug 23;16:483-495. doi: 10.2147/BCTT.S476394. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 39192887 Free PMC article.
A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors.
Wallen ZD, Nesline MK, Pabla S, Gao S, Vanroey E, Hastings SB, Ko H, Strickland KC, Previs RA, Zhang S, Conroy JM, Jensen TJ, George E, Eisenberg M, Caveney B, Sathyan P, Ramkissoon S, Severson EA. Wallen ZD, et al. Among authors: jensen tj. Brief Bioinform. 2024 Sep 23;25(6):bbae557. doi: 10.1093/bib/bbae557. Brief Bioinform. 2024. PMID: 39471413 Free PMC article.
Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors.
Verner EL, Jackson JB, Severson E, Valkenburg KC, Greer AE, Riley DR, Sausen M, Maddox C, McGregor PM 3rd, Karandikar A, Hastings SB, Previs RA, Reddy VP, Jensen TJ, Ramkissoon SH. Verner EL, et al. Among authors: jensen tj. J Mol Diagn. 2023 Jul;25(7):477-489. doi: 10.1016/j.jmoldx.2023.03.008. Epub 2023 Apr 15. J Mol Diagn. 2023. PMID: 37068734 Free article.
Clinical characterization of the mutational landscape of 24,639 real-world samples from patients with myeloid malignancies.
Hogg G, Severson EA, Cai L, Hoffmann HM, Holden KA, Fitzgerald K, Kenyon A, Zeng Q, Mooney M, Gardner S, Chen W, Nagan N, Boles D, Parker S, Richman TJ, Letovsky S, Dong H, Anderson SM, Ramkissoon S, Reddy P, Eisenberg M, Chenn A, Jensen TJ. Hogg G, et al. Among authors: jensen tj. Cancer Genet. 2023 Nov;278-279:38-49. doi: 10.1016/j.cancergen.2023.07.006. Epub 2023 Aug 8. Cancer Genet. 2023. PMID: 37586297 Free article.
122 results